14-day Premium Trial Subscription Try For FreeTry Free
66.90€
+0.250 (+0.375%)
At Close: May 06, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days 5.34€ 19.02€ Monday, 6th May 2024 MOR.DE stock ended at 66.90€. This is 0.375% more than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 0.83% from a day low at 66.40€ to a day high of 66.95€.
90 days 17.30€ 19.02€
52 weeks 16.32€ 20.85€

Historical MorphoSys AG prices

Date Open High Low Close Volume
May 06, 2024 66.55€ 66.95€ 66.40€ 66.90€ 46 604
May 03, 2024 66.00€ 67.00€ 66.00€ 66.65€ 72 984
May 02, 2024 66.10€ 66.30€ 65.60€ 66.10€ 313 371
Apr 30, 2024 65.50€ 67.00€ 65.50€ 66.20€ 357 848
Apr 29, 2024 67.00€ 67.30€ 65.20€ 65.65€ 1 203 894
Apr 26, 2024 67.75€ 67.85€ 67.75€ 67.85€ 39 191
Apr 25, 2024 67.70€ 67.80€ 67.70€ 67.75€ 56 527
Apr 24, 2024 67.70€ 67.75€ 67.70€ 67.70€ 63 222
Apr 23, 2024 67.80€ 67.90€ 67.70€ 67.75€ 55 900
Apr 22, 2024 67.75€ 67.85€ 67.70€ 67.75€ 131 745
Apr 19, 2024 67.70€ 67.70€ 67.70€ 67.70€ 59 669
Apr 18, 2024 67.70€ 67.80€ 67.70€ 67.70€ 139 698
Apr 17, 2024 67.65€ 67.85€ 67.65€ 67.70€ 122 121
Apr 16, 2024 67.90€ 68.00€ 67.60€ 67.70€ 1 405 984
Apr 15, 2024 67.85€ 68.00€ 67.85€ 67.95€ 1 728 595
Apr 12, 2024 67.55€ 68.00€ 67.55€ 67.95€ 2 164 879
Apr 11, 2024 67.10€ 67.60€ 67.10€ 67.60€ 286 198
Apr 10, 2024 67.05€ 67.20€ 67.05€ 67.15€ 142 594
Apr 09, 2024 67.00€ 67.10€ 66.85€ 67.05€ 90 725
Apr 08, 2024 67.10€ 67.20€ 67.00€ 67.00€ 70 732
Apr 05, 2024 67.10€ 67.25€ 67.05€ 67.05€ 210 216
Apr 04, 2024 67.15€ 67.25€ 67.10€ 67.20€ 141 744
Apr 03, 2024 67.25€ 67.35€ 67.20€ 67.25€ 96 708
Apr 02, 2024 67.20€ 67.30€ 67.15€ 67.25€ 111 409
Mar 28, 2024 67.22€ 67.24€ 67.20€ 67.20€ 100 985
Click to get the best stock tips daily for free!

About MorphoSys AG

MorphoSys AG MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, follicular lymphoma, and marginal zone lymphoma. The company also develops Pelabresib, a small molecule ... MOR.DE Profile

Golden Star

Ticker Date Change Price
TMO May 02 0.403% $571.25
STNG May 02 0.699% $71.50
DLR May 02 2.58% $140.15
RF May 02 0.97% $19.64
INVH May 02 0.87% $34.50
SMAR May 02 2.24% $38.39
BIRK May 02 0.650% $44.61
FTSL May 02 0.217% $46.11
VCSH May 02 0.287% $76.71
VRNT May 02 2.44% $30.78
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT